Nasdaq Determines That Transcode Therapeutics Has Regained Compliance With Continued Listing Requirements
納斯達克認定Transcode Therapeutics已經重新符合繼續上市的要求。
Nasdaq Determines That Transcode Therapeutics Has Regained Compliance With Continued Listing Requirements
納斯達克認定Transcode Therapeutics已經重新符合繼續上市的要求。
譯文內容由第三人軟體翻譯。